Herein, we particularly focus on the changes of interleukin (IL)-6 and interferon (IFN)-γ among proinflammatory cytokines; and adiponectin and leptin among adipokines in NAFLD patients with LMF-HSFx or placebo treatment. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.